Rethinking Clinical Trials

JANUARY 17, 2024

The first drug that used the new process was Remdesivir in May 2020. The committee worked with communications specialists who partnered with palliative care providers and others to draft FAQs and other communication guidance for clinician teams who were having conversations about drug allocations with patients and families.

Clinical Trials 169

Clinical Trials Clinical Trials Antibody Trials 169

Rethinking Clinical Trials

JUNE 29, 2022

Center for Drug Evaluation and Research (CDER). Food and Drug Administration (FDA). With the 21st Century Cures Act of 2016, the FDA established a program to evaluate the potential use of real-world evidence to support new indications for drugs and satisfy post-approval study requirements. John Concato, MD, MS, MPH.

Big Data 130

Big Data Clinical Trials Clinical Trials Drugs 130

Rethinking Clinical Trials

JULY 27, 2022

ACTIV-6 is testing medication doses approved by the FDA for other purposes, i.e., repurposed drugs. Given the history with other repurposed drugs, I was concerned people would not want to take Ivermectin. This was one of the reasons we gave people options about which drugs they were willing to take. Professor of Medicine.

Trials 169

Trials Pharmacy Medicine Clinical Trials 169

Rethinking Clinical Trials

DECEMBER 20, 2023

Yet enrollment of ethnic minorities in NIH clinical trials and for trials studying approved devices and drugs remains low. Globally cardiovascular disease (CVD) prevalence had decreased between 1990 and 2010, but it has slightly increased since 2010.

Clinical Trials 169

Clinical Trials Clinical Trials Trials Cardiology 169

Rethinking Clinical Trials

MARCH 1, 2023

For the standard of care arm, treatment is determined by the treating investigator and participant, with the recommendation that the choice of drug is based on NCCN guidelines and dosing administration based on the participant’s previous therapy and disease. – What was the rationale for the choice of study treatments (i.e.,

Clinical Trials 130

Clinical Trials Clinical Trials Trials Packaging 130

pharmaphorum

NOVEMBER 13, 2020

Each country has different regulations in regard to the online advertising of prescription drugs and over-the-counter medicines. Ensure keywords used are relevant for your audience – medical terminology for professionals and informational keywords providing solutions to ailments for consumers.

Branding 102

Branding Pharmacy Marketing Compliance 102

Roots Analysis

NOVEMBER 3, 2023

NAMPT inhibitors are a class of drugs that target the enzyme nicotinamide phosphoribosyltransferase (NAMPT). One of the main challenges is the development of drug resistance, as cancer cells can develop mechanisms to bypass the inhibition of NAMPT. Several trials focused on evaluation of such drugs were discontinued in the past.

Development 40

Development Drugs Trials FDA Approval 40